Single-use technology and modular construction

BioProcess International

Volumn 11, Issue SUPPL. 4, 2013, Pages 40-45

  Levine, Howard L ^a   Stock, Rick ^a   Lilja, Jan E ^b   Gaasvik, Åsa ^b   Hummel, Hans ^b   Ransohoff, Thomas C ^a   Jones, Susan Dana ^c  

^a BioProcess Technology Consultants Inc   (United States)

^b Senior Design Engineer at KeyPlants AB ^*  (Sweden)

^c Senior consultants with BioProcess Technology Consultants Inc   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOREACTOR; BIOTECHNOLOGICAL PRODUCTION; COST EFFECTIVENESS ANALYSIS; DRUG DESIGN; DRUG INDUSTRY; DRUG MANUFACTURE; ECONOMIC ASPECT; EUROPE; PHARMACEUTICAL ENGINEERING; UNITED STATES;

EID: 84876486942     PISSN: 15426319     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article

References (13)

1. Levine HL, et al. Efficient, Flexible Facilities for the 21st Century. BioProcess Int. 10(11) 2012: S20-S30.
2. Sinclair A, Monge M. Disposables Cost Contributions: A Sensitivity Analysis. BioPharm Int. 22(4) 2009: 1418.
3. BioProcess Technology Consultants, Inc. The Development of Therapeutic Monoclonal Antibody Products. Levine HL, Jagschies G, Eds. Elanders Sverige AB: Molnlycke, Sweden February 2010.
4. Mauter M. Environmental Life-Cycle Assessment of Disposable Bioreactors. BioProcess Int. 8(4) 2009: 1828.
5. Pietrzykowski M, et al. An Environmental Life-Cycle Assessment Comparing Single-Use and Conventional Process Technology. BioPharm Int. 24, 2011: S30-S38.
6. Rawlings B, Pora H. Environmental Impact of Single-Use and Reusable Bioprocess Systems. BioProcess Int. 7(2) 2009: 1826.
7. Hodge G. Disposable Components Enable a New Approach to Biopharmaceutical Manufacturing. BioPharm Int. 17(3) 2004: 3849.
8. Hodge G. The Economic and Strategic Value of Flexible Manufacturing Capacity. ISPE Strasbourg Conference: Strasbourg, France, 2829 September 2009. International Society of Pharmaceutical Engineers: Tampa, FL, www.ispe.org.
9. Fromison J. Disposables in Clinical Manufacturing. Am. Pharmaceut. Rev. 12(2) 2009: 2027.
10. Foulon A, et al. Using Disposables in an Antibody Production Process: A Cost-Effectiveness Study of Technology Transfer Between Two Sites. BioProcess Int. 6(6) 2008: 1217.
11. Malcolm F. Implementing Disposable Chromatography-Process and Technology Fit. Biopharmaceutical Development and Production Week: Huntington Beach, CA, 25 February1 March 2013. IBC Life Sciences: Westborough, MA, www.ibclifesciences. com.
12. Gilroy J, Martini G. Modular Construction Considerations. Pharmaceut. Proc. 27(10) 2012: 2223.
13. Jameson P. Modularization: Is It Right for You? CII Annual Conference: Orlando, FL, 2 August 2007. Construction Industry Institute: Austin, TX; www.construction-institute.org.